These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2423911)

  • 1. Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain.
    Lindefors N; Brodin E; Ungerstedt U
    Neuropeptides; 1986 Apr; 7(3):265-80. PubMed ID: 2423911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
    Lindefors N; Brodin E; Ungerstedt U
    Eur J Pharmacol; 1989 Feb; 161(1):95-8. PubMed ID: 2470596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subchronic treatment with imipramine, zimelidine and alaproclate on regional tissue levels of substance P- and neurokinin A/neurokinin B-like immunoreactivity in the brain and spinal cord of the rat.
    Brodin E; Ogren SO; Theodorsson-Norheim E
    Neuropharmacology; 1987 Jun; 26(6):581-90. PubMed ID: 2439937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that neurokinin A (substance K) neurons project from the striatum to the substantia nigra in rats.
    Nagashima A; Takano Y; Masui H; Kamiya H
    Neurosci Lett; 1987 Jun; 77(1):103-8. PubMed ID: 3037449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C; Saria A
    Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
    Oblin A; Zivkovic B
    Fundam Clin Pharmacol; 1991; 5(2):129-38. PubMed ID: 1712746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion in substance P- and neurokinin A-like immunoreactivity in substantia nigra after ibotenate-induced lesions of striatum.
    Arai H; Sirinathsinghji DJ; Emson PC
    Neurosci Res; 1987 Dec; 5(2):167-71. PubMed ID: 2448711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A.
    Brodin E; Lindefors N; Dalsgaard CJ; Theodorsson-Norheim E; Rosell S
    Regul Pept; 1986 Feb; 13(3-4):253-72. PubMed ID: 2422706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchronic haloperidol and sulpiride treatment induces region-specific changes in tissue levels of putative amino acid transmitters in rat brain.
    Lindefors N; Tossman U; Ungerstedt U
    Neurosci Lett; 1987 Feb; 74(1):90-4. PubMed ID: 2882448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.
    Arai H; Emson PC
    Brain Res; 1986 Dec; 399(2):240-9. PubMed ID: 2435360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo detection of immunoreactive neurokinin A release within rat substantia nigra and its dependency on a dopaminergic input.
    Furmidge LJ; Duggan AW; Arbuthnott GW
    Brain Res; 1995 May; 679(2):241-8. PubMed ID: 7633884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsaicin-induced release of neurokinin A from muscle and mucosa of gastric corpus: correlation with capsaicin-evoked release of calcitonin gene-related peptide.
    Renzi D; Evangelista S; Mantellini P; Santicioli P; Maggi CA; Geppetti P; Surrenti C
    Neuropeptides; 1991 Jul; 19(3):137-45. PubMed ID: 1716741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatment.
    Hanson GR; Letter AA; Merchant K; Gibb JW
    Peptides; 1986; 7(6):983-7. PubMed ID: 2436197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in substance P concentrations after protein synthesis inhibition provide an index of substance P utilization.
    Bannon MJ; Goedert M
    Brain Res; 1984 May; 301(1):184-6. PubMed ID: 6203608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y; Kobayashi K; Shohmori T
    Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
    J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.